Shares of Danish pharmaceutical giant Novo Nordisk plummeted more than 22% on Friday after reporting results in a late-stage trial that missed expectations.
Related Posts
Trump downplays tariff deals as U.S. trade talks falter
U.S. markets moved lower Tuesday after Trump’s comments on trade deals.
Here’s how Musk’s access to Treasury system may impact Social Security, other government payments
The new Department of Government Efficiency now has access to a federal system responsible for $6 trillion in annual payments.
Trump says U.S. will remove all sanctions on Syria
Syria has been designated a State Sponsor of Terrorism by the U.S. government since 1979.